These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25082210)

  • 21. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration.
    Hecq J; Siepmann F; Siepmann J; Amighi K; Goole J
    Drug Dev Ind Pharm; 2015; 41(12):2037-44. PubMed ID: 26006329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
    Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
    Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and cytotoxicity of N-modified chitosan nanoparticles applied in curcumin delivery.
    Facchi SP; Scariot DB; Bueno PV; Souza PR; Figueiredo LC; Follmann HD; Nunes CS; Monteiro JP; Bonafé EG; Nakamura CV; Muniz EC; Martins AF
    Int J Biol Macromol; 2016 Jun; 87():237-45. PubMed ID: 26930578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase.
    Liao J; Ren X; Yang B; Li H; Zhang Y; Yin Z
    Drug Dev Ind Pharm; 2019 Jan; 45(1):88-95. PubMed ID: 30198790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonic targeting insulin-loaded trimethyl chitosan nanoparticles coated pectin for oral delivery: In vitro and In vivo studies.
    Seyam S; Choukaife H; Al Rahal O; Alfatama M
    Int J Biol Macromol; 2024 Nov; 281(Pt 4):136549. PubMed ID: 39401622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.
    Ganesan P; Ramalingam P; Karthivashan G; Ko YT; Choi DK
    Int J Nanomedicine; 2018; 13():1569-1583. PubMed ID: 29588585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
    Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
    Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhodojaponin III-Loaded Chitosan Derivatives-Modified Solid Lipid Nanoparticles for Multimodal Antinociceptive Effects in vivo.
    Yang Q; Yang J; Sun S; Zhao J; Liang S; Feng Y; Liu M; Zhang J
    Int J Nanomedicine; 2022; 17():3633-3653. PubMed ID: 35996527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
    Wang T; Ma X; Lei Y; Luo Y
    Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin.
    Zheng Y; Chen Y; Jin LW; Ye HY; Liu G
    AAPS PharmSciTech; 2016 Dec; 17(6):1347-1352. PubMed ID: 26718819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
    Jaafar MHM; Hamid KA
    Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
    Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
    Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
    van der Merwe SM; Verhoef JC; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Jan; 57(1):85-91. PubMed ID: 14729083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeted SLNs for management of HIV-1 associated dementia.
    Rai A; Jain A; Jain A; Jain A; Pandey V; Chashoo G; Soni V; Sharma PR
    Drug Dev Ind Pharm; 2015; 41(8):1321-7. PubMed ID: 25113430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.